Next report date
Report period
Q1 2024
EPS estimate
−0.11USD
Revenue estimate
41.81 MUSD
−62.26 MUSD
163.91 MUSD
125.57 M
Om Xeris Biopharma Holdings, Inc.
Sektor
Bransch
VD
Paul R. Edick
Webbplats
Huvudkvarter
Chicago
Employees (FY)
377
Grundat
2005
FIGI
BBG012YNKCH9
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
